A confidential disclosure Agreement (CDA) is a legal contract that outlines confidential information that may be shared between at least two entities but is not allowed to be shared with third parties.
OCR Contracts require a fully executed Confidentiality Agreement (CDA) to accompany all new Clinical Trial Agreement (CTA) submissions. Principal investigators should not be engaged in study-related discussions with third parties unless a CDA is in place.
Principal investigators are not authorized to sign any confidentiality agreements prior to review and negotiation by the appropriate contracting office.